Noble Financial upgrades CardioNet (Nasdaq: BEAT) to Buy. Price target $8.

Noble analyst says, "Pricing appears to be settling ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE